- Report
- March 2024
- 193 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Report
- September 2023
- 120 Pages
Global
From €5653EUR$5,950USD£4,863GBP
- Report
- April 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- February 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- February 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- February 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- January 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- November 2023
- 141 Pages
Global
From €2374EUR$2,499USD£2,042GBP
- Report
- October 2023
- 181 Pages
Global
From €4655EUR$4,900USD£4,005GBP
- Report
- July 2023
- 135 Pages
Global
From €7125EUR$7,500USD£6,129GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1900EUR$2,000USD£1,634GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1425EUR$1,500USD£1,226GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1188EUR$1,250USD£1,022GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1425EUR$1,500USD£1,226GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1425EUR$1,500USD£1,226GBP
- Report
- November 2023
- 189 Pages
Global
From €4655EUR$4,900USD£4,005GBP
- Report
- October 2023
- 145 Pages
Global
From €2993EUR$3,150USD£2,574GBP
- Report
- November 2023
- 140 Pages
Global
From €4228EUR$4,450USD£3,637GBP
- Report
- June 2023
- 104 Pages
Global
From €4228EUR$4,450USD£3,637GBP
- Report
- June 2023
- 204 Pages
Global
From €3420EUR$3,600USD£2,942GBP
Buprenorphine is an analgesic medication used to treat moderate to severe pain. It is a semi-synthetic opioid derived from thebaine, an alkaloid found in the opium poppy. Buprenorphine is available in both immediate-release and extended-release formulations, and is typically administered orally or sublingually. It is commonly used in combination with other analgesics, such as acetaminophen or ibuprofen, to provide more effective pain relief.
Buprenorphine is a popular choice for treating chronic pain due to its long-lasting effects and low risk of addiction. It is also used to treat opioid addiction, as it has a lower potential for abuse than other opioids. Buprenorphine is available in generic form, as well as under brand names such as Subutex and Suboxone.
Some companies in the buprenorphine market include Reckitt Benckiser, Indivior, Mylan, and Dr. Reddy's Laboratories. Show Less Read more